Randomized clinical trial to assess the efficacy of radiotherapy in primary mediastinal large B-lymphoma

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 4, 2012, Pages 1227-1231

  Avilés, Agustin ^a   Neri, Natividad ^a   Fernández, Raúl ^a   Huerta Guzmán, Judith ^a   Nambo, María J ^a  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

Author keywords

Chemotherapy; Doxorubicin; Primary mediastinal lymphoma; Radiotherapy; Rituximab

Indexed keywords

ACUTE TOXICITY; ADJUVANT RADIOTHERAPY; B-CELL LYMPHOMA; CLINICAL TRIAL; COMPLETE RESPONSE; CONTROL GROUPS; DOXORUBICIN; OVERALL SURVIVAL; PRIMARY MEDIASTINAL LYMPHOMA; RANDOMIZED CLINICAL TRIALS; RITUXIMAB; SECURITY ANALYSIS;

CHEMOTHERAPY; DIAGNOSIS; EXPERIMENTS; ONCOLOGY; TOXICITY;

RADIOTHERAPY;

BETA 2 MICROGLOBULIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; LACTATE DEHYDROGENASE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ACUTE TOXICITY; ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EOSINOPHIL COUNT; FEMALE; FOLLOW UP; GRANULOCYTOPENIA; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INVOLVED FIELD RADIOTHERAPY; LABORATORY TEST; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PHYSICAL EXAMINATION; PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE COUNT; TREATMENT RESPONSE;

ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; EARLY TERMINATION OF CLINICAL TRIALS; FEMALE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MEDIASTINAL NEOPLASMS; MEXICO; PREDNISONE; RADIOTHERAPY, ADJUVANT; VINCRISTINE;

EID: 84862650010     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.09.012     Document Type: Article

References (23)

1. Rodriguez J, Gutierrez A, Piris M, et al. Primary mediastinal B-cell lymphoma: Treatment and therapeutic targets. Leuk Lymphoma 2008; 49:1050-1061.
2. Martelli M, Ferreri AJ, Johnson P. Primary mediastinal large B-cell lymphoma. Crit Rev Oncol Hematol 2008;68:256-263.
3. Van Besien K, Kelta M, Bahaguna P. Primary mediastinal B-cell lymphoma. A review of pathology and treatment. J Clin Oncol 2001; 19:1855-1864.
4. Jacobson JV, Aisenberg AC, Lemarre L, et al. Mediastinal larg-e cell lymphoma. Cancer 1998;62:1898-1899.
5. Kirn D, Mauch P, Shaffer K, et al. Large cell and immunoblastic lymphoma of the mediastinum: Prognostic features and treatment outcome in 57 patients. J Clin Oncol 1993;11:1336-1343.
6. Massoud M, Kosciorny S, Lapusan N, et al. Primary mediastinal large B-cell lymphoma treated with dose-intensified CHOP alone or CHOP combined with radiotherapy. Leuk Lymphoma 2008;49:1510-1515.
7. Avilés A, García EL, Fernandez R, Gonzalez JL, Neri N, Díaz- Maqueo JC. Combined therapy in the treatment of primary mediastinal B-cell lymphoma: Conventional versus escalated chemotherapy. Ann Hematol 2002;81:368-371.
8. Siracusano C, Balzarotti M, Magagnoli M, et al. Primary mediastinal B-cell lymphoma with sclerosis. Am J Hematol 2005;78:312-313.
9. Kolconié SV, DZebro S, Kusec P, et al. Primary mediastinal large B-cell lymphoma. Int J Haematol 2006;83:331-336.
10. Mazzarotto R, Boso C, Vianello F, et al. Primary mediastinal large Bcell lymphoma. Results of intensive chemotherapy regimen (MACOPB/ VACOP-B) plus involved field radiotherapy in 53 patients. Int J Radiat Oncol Biol Phys 2007;68:823-829.
11. DeSanctis V, Finolezzi E, Osti MF, et al. MACOP-B and involved radiotherapy is an effective and safe therapy for primarymediastinal large B-cell lymphoma. Int J Radiat Oncol Biol Phys 2008;72:1154-1162.
12. Zinzani PL, Martelli M, Bertini M, et al. Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis. Haematologica 2002;87:1258-1264.
13. Sacage KJ, Al-Rajhi N, Voss C, et al. Favorable outcome of primary mediastinal large B-cell lymphoma in an single institution. Ann Oncol 2006;17:123-130.
14. Vassolakopulos TP, Angelopoulo MK, Galani Z, et al. Rituximab -CHOP (R-CHOP) and radiotherapy for primary mediastinal large B-cell lymphoma (abstract 2745). Blood 2005;106(Suppl 1).
15. Dunleavy K, Pitaluga S, Jank J, et al. Primary mediastinal large B-cell lymphoma outcome is significantly improved by the addition of rituximab to dose adjusted EPHOCH and overcome the use of radiotherapy (Abstract 929). Blood 2006;108(Suppl 1).
16. Wirth A. The rationale and role of radiation therapy in the treatment of patients with diffuse large B-cell lymphoma in the rituximab era. Leuk Lymphoma 2007;48:2121-2136.
17. Martelli M, Stefori V, Cabral G, et al. MACOP-B or VACOP-B + Rituximab in the treatment of primary mediastinal B-cell lymphoma (Abstract 4697). Blood 2006;108(Suppl 1).
18. Cheson BD, Horning SJ, Coiffier B, et al. Report of an International Workshop to standardize response criteria for non-Hodgkin's lymphoma. J Clin Oncol 1997;17:1244-1254.
19. Zinzani PL, Stefoni V, Finolezzi E, et al. Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma. Clin Lymphoma Myeloma 2009;9: 381-385.
20. Ahn HK, Kiam SJ, Yi OH, et al. Improved outcome of primary mediastinal large B-cell lymphoma after induction of chemotherapy and rituximab in Korean patients. Int J Hematol 2010;91: 456-463.
21. Rieger M, Östenborg A, Pettengel R, et al. Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab. Ann Oncol 2011;22:664-670.
22. Fietz T, Knauf WU, Hänel M, et al. Treatment of primary mediastinal large B-cell lymphoma with an alternating chemotherapy regimen based on high-dose chemotherapy. Ann Hematol 2009;88:433-449.
23. Pugh TJ, Ballono FF, Rusthoven KE, et al. Cardiac mortality in patients with stage I and II diffuse large B-cell lymphoma treated with or without radiotherapy. Int J Radiat Oncol Biol Phys 2010;76: 841-848.